Delivery Order SPE2DB22D3004-SPE2DB25FSD55
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,562.51 on September 18, 2025, for the supply of Emgality 300 mg (100 mg x3 syringe/mL) under a Defense Logistics Agency Medical Supply Chain contract. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task against...
- The Defense Logistics Agency awarded a delivery order valued at $7,257.28 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Emgality 300 mg (100 mg x3 syringe/mL). This competitive award, which carries no set-aside designation, is structured as a firm fixed-price contract with an ultimate completion date of September 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary place of...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,036.60 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Emgality 120 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a $3,348 delivery order by the Defense Logistics Agency (DLA) on November 5, 2025, for the supply of Emgality 120 mg/ml in pen format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 6, 2025, and performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.00 to AmerisourceBergen Drug Corp for the supply of Emgality 300 mg (100 mg x3 syringe/mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, the headquarters location of the prime contractor....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,088.94 to AmerisourceBergen Drug Corp for the supply of Emgality 300 mg (100 mg x 3 syringes). This firm fixed-price, non-set-aside delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution center. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,729.00 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Emgality 120 mg/mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- This delivery order, valued at $1,547.00, awards Emgality 300 mg pharmaceutical product to AmerisourceBergen Drug Corp under a Defense Logistics Agency (DLA) contract. The order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,729.00 by the Defense Logistics Agency on August 26, 2025, for the supply of Emgality 120 mg/ml pen injections. This is a firm fixed price, non-set-aside contract with a completion date of August 27, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $11,044.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 300 mg (100 mg x 3 syringe/ml) on June 2, 2025, with completion scheduled for June 3, 2025. This non-set-aside award was competitively procured and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...